BindingDB logo
myBDB logout

null

SMILES: Cc1ncc(c(C)n1)-c1cnc(NCc2c3CCOc3ccc2F)n2cnc(C#N)c12

InChI Key: InChIKey=IIIOCCSATMOANP-UHFFFAOYSA-N

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 450873   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Histone-lysine N-methyltransferase EZH2/Polycomb protein EED/Polycomb protein SUZ12


(Homo sapiens (Human))
BDBM450873
PNG
(8-(2,4-dimethylpyrimidin-5-yl)-5-(((5-fluoro-2,3-d...)
Show SMILES Cc1ncc(c(C)n1)-c1cnc(NCc2c3CCOc3ccc2F)n2cnc(C#N)c12
Show InChI InChI=1S/C22H18FN7O/c1-12-15(8-25-13(2)29-12)17-10-27-22(30-11-28-19(7-24)21(17)30)26-9-16-14-5-6-31-20(14)4-3-18(16)23/h3-4,8,10-11H,5-6,9H2,1-2H3,(H,26,27)
PDB

UniProtKB/SwissProt

antibodypedia
antibodypedia
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 6.80n/an/an/an/an/an/a



Novartis AG

US Patent


Assay Description
To assess the compounds' potency in the EED-H3K27Me3 competition binding assay, compounds were serially diluted 3-fold in DMSO to obtain a total ...


US Patent US10676479 (2020)

More data for this
Ligand-Target Pair
Histone-lysine N-methyltransferase EZH2/Polycomb protein EED/Polycomb protein SUZ12


(Homo sapiens (Human))
BDBM450873
PNG
(8-(2,4-dimethylpyrimidin-5-yl)-5-(((5-fluoro-2,3-d...)
Show SMILES Cc1ncc(c(C)n1)-c1cnc(NCc2c3CCOc3ccc2F)n2cnc(C#N)c12
Show InChI InChI=1S/C22H18FN7O/c1-12-15(8-25-13(2)29-12)17-10-27-22(30-11-28-19(7-24)21(17)30)26-9-16-14-5-6-31-20(14)4-3-18(16)23/h3-4,8,10-11H,5-6,9H2,1-2H3,(H,26,27)
PDB

UniProtKB/SwissProt

antibodypedia
antibodypedia
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 13.2n/an/an/an/an/an/a



Novartis AG

US Patent


Assay Description
Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of eight or twelve concentrat...


US Patent US10676479 (2020)

More data for this
Ligand-Target Pair
Histone-lysine N-methyltransferase EZH2/Polycomb protein EED/Polycomb protein SUZ12


(Homo sapiens (Human))
BDBM450873
PNG
(8-(2,4-dimethylpyrimidin-5-yl)-5-(((5-fluoro-2,3-d...)
Show SMILES Cc1ncc(c(C)n1)-c1cnc(NCc2c3CCOc3ccc2F)n2cnc(C#N)c12
Show InChI InChI=1S/C22H18FN7O/c1-12-15(8-25-13(2)29-12)17-10-27-22(30-11-28-19(7-24)21(17)30)26-9-16-14-5-6-31-20(14)4-3-18(16)23/h3-4,8,10-11H,5-6,9H2,1-2H3,(H,26,27)
PDB

UniProtKB/SwissProt

antibodypedia
antibodypedia
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 13.7n/an/an/an/an/an/a



Novartis AG

US Patent


Assay Description
Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of eight or twelve concentrat...


US Patent US10676479 (2020)

More data for this
Ligand-Target Pair